Welcome to LookChem.com Sign In|Join Free

CAS

  • or

266337-25-1

Post Buying Request

266337-25-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

266337-25-1 Usage

Also known as

D-pipecolic acid

Natural occurrence

Synthesized by plants and animals

Pharmaceutical properties

Role in the synthesis of various drugs and as a potential therapeutic agent in the treatment of neurological disorders

Potential role

Development of new materials and in organic synthesis processes

Check Digit Verification of cas no

The CAS Registry Mumber 266337-25-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,6,3,3 and 7 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 266337-25:
(8*2)+(7*6)+(6*6)+(5*3)+(4*3)+(3*7)+(2*2)+(1*5)=151
151 % 10 = 1
So 266337-25-1 is a valid CAS Registry Number.

266337-25-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (4S)-1-(tert-butoxycarbonyl)-4-hydroxy-L-prolinamide

1.2 Other means of identification

Product number -
Other names (2S,4S)-TERT-BUTYL 2-CARBAMOYL-4-HYDROXYPYRROLIDINE-1-CARBOXYLATE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:266337-25-1 SDS

266337-25-1Downstream Products

266337-25-1Relevant articles and documents

QUINAZOLINE DERIVATIVES

-

Page/Page column 96, (2008/06/13)

The invention concerns quinazoline derivatives of Formula (I) wherein each of R1, R3, R20, X1, X2, Z, W, (a) and (q) have any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an antiproliferative agent in the prevention or treatment of turnours which are sensitive to inhibition of erbB receptor tyrosine kinases, particularly EGFR tyrosine kinase.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 266337-25-1